| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/05/2023 | INCYTE CORP | INCY | Grant | Common Stock | 179.6k | $0.00 | $0 | | 06/05/2023 |
| 02/01/2023 | Rubius Therapeutics, Inc. | RUBY | Sale | Common Stock | 8.4k | $0.25 | $2.1k | | 02/01/2023 |
| 06/14/2022 | Fusion Pharmaceuticals Inc. | FUSN | Grant | Stock Option (Right to Buy) | 17k | $3.60 | $61.2k | | 06/14/2022 |
| 02/01/2022 | Rubius Therapeutics, Inc. | RUBY | Sale | Common Stock | 6.7k | $6.57 | $44.2k | | 01/29/2022 |
| 01/31/2022 | Rubius Therapeutics, Inc. | RUBY | Grant | Restricted Stock Units | 100k | $0.00 | $0 | | 01/29/2022 |
| 01/31/2022 | Rubius Therapeutics, Inc. | RUBY | Grant | Stock Option (Right to Buy) | 365k | $6.75 | $2.5M | | 01/29/2022 |
| 01/29/2022 | Rubius Therapeutics, Inc. | RUBY | Exercise | Restricted Stock Units | 21.2k | $0.00 | $0 | | 01/29/2022 |
| 06/04/2021 | Fusion Pharmaceuticals Inc. | FUSN | Grant | Stock Option (Right to Buy) | 17k | $8.15 | $138.6k | | 06/04/2021 |
| 01/29/2021 | Rubius Therapeutics, Inc. | RUBY | Grant | Restricted Stock Units | 85k | $0.00 | $0 | | 01/29/2021 |
| 01/29/2021 | Rubius Therapeutics, Inc. | RUBY | Grant | Stock Option (Right to Buy) | 375k | $11.97 | $4.5M | | 01/29/2021 |
| 06/25/2020 | Fusion Pharmaceuticals Inc. | FUSN | Grant | Stock Option (Right to Buy) | 30k | $17.00 | $510k | | 06/25/2020 |
| 04/14/2020 | Rubius Therapeutics, Inc. | RUBY | Purchase | Common Stock | 21k | $4.70 | $98.7k | | 04/14/2020 |
| 01/31/2020 | Rubius Therapeutics, Inc. | RUBY | Grant | Stock Option (Right to Buy) | 500k | $7.80 | $3.9M | | 01/31/2020 |
| 11/19/2019 | CRISPR Therapeutics AG | CRSP | Exercise | Stock Option (Right to Buy) | 7.5k | $5.59 | $41.9k | | 11/19/2019 |
| 11/19/2019 | CRISPR Therapeutics AG | CRSP | Sale | Common Shares | 7.5k | $62.00 | $465k | | 11/19/2019 |
| 11/12/2019 | CRISPR Therapeutics AG | CRSP | Exercise | Stock Option (Right to Buy) | 7.5k | $5.59 | $41.9k | | 11/12/2019 |
| 11/12/2019 | CRISPR Therapeutics AG | CRSP | Sale | Common Shares | 7.5k | $55.00 | $412.5k | | 11/12/2019 |
| 10/30/2019 | CRISPR Therapeutics AG | CRSP | Sale | Common Shares | 7.5k | $52.00 | $390k | | 10/30/2019 |
| 10/30/2019 | CRISPR Therapeutics AG | CRSP | Exercise | Stock Option (Right to Buy) | 7.5k | $5.59 | $41.9k | | 10/30/2019 |
| 06/11/2019 | CRISPR Therapeutics AG | CRSP | Grant | Stock Option (Right to Buy) | 15k | $43.52 | $652.8k | | 06/11/2019 |
| 01/31/2019 | Rubius Therapeutics, Inc. | RUBY | Grant | Stock Option (Right to Buy) | 100k | $13.69 | $1.4M | | 01/31/2019 |
| 10/31/2018 | Rubius Therapeutics, Inc. | RUBY | Grant | Stock Option (Right to Buy) | 164.4k | $16.43 | $2.7M | | 10/31/2018 |
| 10/31/2018 | Rubius Therapeutics, Inc. | RUBY | Grant | Stock Option (Right to Buy) | 193.4k | $16.43 | $3.2M | | 10/31/2018 |
| 07/05/2018 | CRISPR Therapeutics AG | CRSP | Sale | Common Shares | 1.7k | $62.00 | $104.4k | | 07/03/2018 |
| 07/05/2018 | CRISPR Therapeutics AG | CRSP | Exercise | Stock Option (Right to Buy) | 1.7k | $5.59 | $9.4k | | 07/03/2018 |
| 07/03/2018 | CRISPR Therapeutics AG | CRSP | Sale | Common Shares | 5.8k | $62.00 | $360.6k | | 07/03/2018 |
| 07/03/2018 | CRISPR Therapeutics AG | CRSP | Exercise | Stock Option (Right to Buy) | 5.8k | $5.59 | $32.5k | | 07/03/2018 |
| 06/15/2018 | CRISPR Therapeutics AG | CRSP | Grant | Stock Option (Right to Buy) | 15k | $59.31 | $889.6k | | 06/15/2018 |
| 10/18/2016 | CRISPR Therapeutics AG | CRSP | Grant | Stock Option (Right to Buy) | 15k | $14.00 | $210k | | 10/18/2016 |
| 03/11/2013 | ONYX PHARMACEUTICALS INC | ONXX | Grant | Common Stock | 16.3k | $0.00 | $0 | | 03/11/2013 |
| 03/11/2013 | ONYX PHARMACEUTICALS INC | ONXX | Grant | Stock Option (Right to Buy) | 34k | $87.83 | $3M | | 03/11/2013 |